|
|
|
|
LEADER |
02073nmm a2200337 u 4500 |
001 |
EB001123016 |
003 |
EBX01000000000000000855899 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
160204 ||| eng |
100 |
1 |
|
|a Frazier, Kendall S.
|
245 |
0 |
0 |
|a Antisense oligonucleotides
|h Elektronische Ressource
|b the promise and the problems
|c Kendall S. Frazier
|
260 |
|
|
|a London
|b Henry Stewart Talks
|c 2015, 2015
|
300 |
|
|
|a 1 online resource (1 streaming video file (45 min.)
|b color, sound)
|
505 |
0 |
|
|a Antisense oligonucleotide (ASOs) therapies -- Screening strategies for drug candidates -- Locked nucleic acid (LNA) gapmers -- Understanding off-target effects (OTEs) -- Mechanisms of ASO toxicity and clinical relevance -- New targets/delivery systems under development
|
653 |
|
|
|a Toxicity Tests
|
653 |
|
|
|a Patient Safety
|
653 |
|
|
|a Drug Discovery / methods
|
653 |
|
|
|a Oligonucleotides, Antisense / toxicity
|
653 |
|
|
|a Antisense nucleic acids
|
653 |
|
|
|a Oligonucleotides, Antisense / adverse effects
|
653 |
|
|
|a Oligonucleotides, Antisense / therapeutic use
|
653 |
|
|
|a Drug development
|
653 |
|
|
|a Toxicity testing
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b HST
|a Henry Stewart Talks
|
490 |
0 |
|
|a Future directions in therapeutic intervention, diagnostics and prophylactics
|
500 |
|
|
|a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web. - System requirements: Browser compatibility: updated Mozilla Firefox, Google Chrome, Safari or Internet Explorer 8+. Browser settings: enable JavaScript, enable cookies from the Henry Stewart Talks site. Required Desktop Browser plugins & viewers: Updated Adobe Flash Player & Adobe Acrobat Reader. Mobile device & operating system versions: Android v4.0+, iPhone 4+ (iOS v6.x+), iPad 2+ (iOS v6.x+), BlackBerry OS v7.0+, Windows Phone v6.5.1+
|
856 |
4 |
0 |
|u https://hstalks.com/bs/3174
|x Verlag
|z Streaming video file
|
856 |
4 |
2 |
|u https://hstalks.com/bs/p/1027
|3 Series
|
082 |
0 |
|
|a 570
|